Zomedica (US:ZOM) ZACKSยท2025-05-15 23:36Company Performance - Zomedica Corp. reported a quarterly loss of $0.02 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.01, marking an earnings surprise of -100% [1] - The company posted revenues of $6.5 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 16.45%, compared to revenues of $6.26 million a year ago [2] - Zomedica has not surpassed consensus EPS estimates over the last four quarters [2] Stock Movement and Outlook - Zomedica shares have declined approximately 51.6% since the beginning of the year, while the S&P 500 has gained 0.2% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for stock performance [4] - The current consensus EPS estimate for the coming quarter is -$0.01 on revenues of $8.49 million, and -$0.03 on revenues of $35.16 million for the current fiscal year [7] Industry Context - The Medical - Instruments industry, to which Zomedica belongs, is currently in the top 34% of over 250 Zacks industries, indicating a favorable industry outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Zomedica's stock performance [5]